Plasma adiponectin as a predictive factor of survival after a bypass operation for peripheral arterial disease

Hiroyoshi Komai, Rei Shibata, Masanobu Juri, Kunihiro Matsushita, Noriyuki Ouchi, Toyoaki Murohara

Research output: Contribution to journalArticlepeer-review


Objective: We investigated an association between adiponectin and long-term survival in patients requiring an arterial bypass operation for peripheral arterial disease. Methods: An enzyme-linked immunosorbent assay kit was used to measure plasma adiponectin levels in 49 patients (38 men, 11 women) before they underwent an arterial bypass operation. Median patient age was 70 years (range, 49-90 years). The study excluded patients with hemodialysis requirement, heart failure, malignant neoplasm, or collagen disease. The symptoms at the first visit were severe intermittent claudication in 27 patients (55%) and critical limb ischemia with rest pain or ulcer, or both, in 22 (45%). Results: Plasma adiponectin levels were a mean 7.8 ± 5.3 μg/mL (range, 1.0-25.2 μg/mL). Multiple regression analyses revealed that plasma adiponectin was positively correlated with age (r = 0.49, P = .0003) and negatively correlated with body mass index (r = -0.51, P = .0002) and systolic blood pressure (r = -0.41, P = .0059). The Cox proportional hazards model revealed that plasma adiponectin (hazard ratio, 1.30; P = .03) and critical limb ischemia (hazard ratio, 16.67; P = .047) were significant independent predictors of patient survival after a bypass operation. Conclusion: Plasma adiponectin could be indicative of mortality after a bypass operation for patients with advanced peripheral arterial disease.

Original languageEnglish (US)
Pages (from-to)95-99
Number of pages5
JournalJournal of vascular surgery
Issue number1
StatePublished - Jul 2009
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Plasma adiponectin as a predictive factor of survival after a bypass operation for peripheral arterial disease'. Together they form a unique fingerprint.

Cite this